Survey of general practitioners' attitudes to prescribing statins in different patient groups: A web-based survey

Scottish Medical Journal

Volumn 56, Issue 1, 2011, Pages 33-35

  Macklin, J ^a,b   Morrison, G ^b  

^a Ailsa Hospital   (United Kingdom)

^b Crichton Royal Hospital   (United Kingdom)

Author keywords

Cardiovascular risk; Schizophrenia; Statin

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; E-MAIL; EPILEPSY; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; PRESCRIPTION; RISK FACTOR; SCHIZOPHRENIA; VIGNETTE; WEB BASED SURVEY;

ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPILEPSY; HEALTH CARE SURVEYS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERNET; PHYSICIANS; QUESTIONNAIRES; RISK FACTORS; SCHIZOPHRENIA;

EID: 79959346123     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1258/smj.2010.010016     Document Type: Article

References (15)

1. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risk of cardiovascular disease. Am Heart J 2006;151:e8
2. Stark C, MacLeod M, Hall D, O'Brien F, Pelosi A. Mortality after discharge from long-term psychiatric care in Scotland, 1977-1994: a retrospective cohort study. BMC Public Health 2003;3:30
3. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia. Br J Psychiatry 2003;183:534-9
4. Maudsley H. The Pathology of Mind. 3rd edn. London: Pinter Pub Ltd, 1983
5. Cohen D. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Pharmacopsychiatry 2004;37:1-11
6. Sernyak M, Leslie D, Alarcon R, Losonczy M, Rosenheck R. Association of diabetes mellitus with the use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-6
7. Kelly C, McCreadie R. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 1999;156:1751-7
8. McEvoy J, Freudenreich O, Levin E, Rose J. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 1995; 119:124-6
9. Siris S. Depression in schizophrenia: perspective in the era of 'atypical' antipsychotic agents. Am J Psychiatry 2000;157:1379-89
10. Abas M, Htotpf M, Prince M. Depression and mortality in a highrisk population II-Year follow-up of the Medical Research Council Elderly Hypertension Trial. Br J Psychiatry 2002;181:123-8
11. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819-25
12. Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006;86:15-22
13. Osborn DP, King MB, Nazareth I. Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice. BMJ 2003;326: 1122-3
14. McDonald D, Frakes M, Apostolidis B, Goldbatt S, Bernardo D. Effect of psychiatric diagnosis on nursing care for nonpsychiatric problems. Res Nurs Health 2003;26:225-32
15. Druss B, Bradford D, Rosenheck R, Radford M, Krumholz H. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000;283:506-11